Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
J Mater Sci Mater Med ; 29(6): 78, 2018 Jun 01.
Article in English | MEDLINE | ID: mdl-29858670

ABSTRACT

Due to its biological properties, human amniotic membrane (hAM) is widely studied in the field of tissue engineering and regenerative medicine. hAM is already very attractive for wound healing and it may be helpful as a support for bone regeneration. However, few studies assessed its potential for guided bone regeneration (GBR). The purpose of the present study was to assess the potential of the hAM as a membrane for GBR. In vitro, cell viability in fresh and cryopreserved hAM was assessed. In vivo, we evaluated the impact of fresh versus cryopreserved hAM, using both the epithelial or the mesenchymal layer facing the defect, on bone regeneration in a critical calvarial bone defect in mice. Then, the efficacy of cryopreserved hAM associated with a bone substitute was compared to a collagen membrane currently used for GBR. In vitro, no statistical difference was observed between the conditions concerning cell viability. Without graft material, cryopreserved hAM induced more bone formation when the mesenchymal layer covered the defect compared to the defect left empty. When associated with a bone substitute, such improved bone repair was not observed. These preliminary results suggest that cryopreserved hAM has a limited potential for GBR.


Subject(s)
Amnion/chemistry , Bone Regeneration/drug effects , Bone Substitutes/chemistry , Collagen/chemistry , Guided Tissue Regeneration , Animals , Biocompatible Materials , Bone and Bones/metabolism , Cell Survival , Cryopreservation , Durapatite/chemistry , Female , Humans , Mice , Mice, Inbred C57BL , Osteogenesis/drug effects , Regenerative Medicine , Skull/drug effects , Tissue Engineering , Wound Healing/drug effects , X-Rays
2.
Angew Chem Int Ed Engl ; 54(15): 4517-21, 2015 Apr 07.
Article in English | MEDLINE | ID: mdl-25693962

ABSTRACT

Controlling the behavior of stem cells through the supramolecular architecture of the extracellular matrix remains an important challenge in the culture of stem cells. Herein, we report on a new generation of low-molecular-weight gelators (LMWG) for the culture of isolated stem cells. The bola-amphiphile structures derived from nucleolipids feature unique rheological and biological properties suitable for tissue engineering applications. The bola-amphiphile-based hydrogel scaffold exhibits the following essential properties: it is nontoxic, easy to handle, injectable, and features a biocompatible rheology. The reported glycosyl-nucleoside bola-amphiphiles (GNBA) are the first examples of LMWG that allow the culture of isolated stem cells in a gel matrix. The results (TEM observations and rheology) suggest that the supramolecular organizations of the matrix play a role in the behavior of stem cells in 3D environments.


Subject(s)
Biocompatible Materials/chemistry , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Nucleosides/chemistry , Stem Cells/cytology , Surface-Active Agents/chemistry , Cells, Cultured , Glycosylation , Humans , Molecular Weight , Rheology , Tissue Engineering , Tissue Scaffolds/chemistry
3.
Med Sci (Paris) ; 40(1): 92-97, 2024 Jan.
Article in French | MEDLINE | ID: mdl-38299910

ABSTRACT

Pre-implant bone surgery in oral surgery allows to reconstruct maxillary atrophies related to traumatic, infectious or tumoral processes. In this context, the ideal biomaterial remains autogenous bone, but biomaterials (of natural or synthetic origin) allow to limit the morbidity linked to bone harvesting, and to simplify these surgical procedures. In this article, we illustrate how 3D printing technologies can be used as an adjuvant to treat bone defects of complex shape or to create anatomical models used to plan interventions. Finally, some perspectives brought by tissue engineering and bioprinting (creation of complex in vitro models) are presented.


Title: Impression 3D et bioimpression pour la régénération osseuse en chirurgie orale. Abstract: La chirurgie osseuse pré-implantaire en chirurgie orale permet de reconstruire les atrophies des maxillaires en rapport avec des processus traumatiques, infectieux ou tumoraux. Dans ce contexte, le biomatériau idéal reste l'os autogène mais les biomatériaux (d'origine naturelle ou synthétique) permettent de limiter la morbidité liée aux prélèvements osseux et de simplifier ces interventions chirurgicales. Dans cet article, nous illustrons l'apport récent de l'impression 3D dans ce contexte pour traiter des défauts osseux de forme complexe ou pour créer des modèles anatomiques servant à planifier les interventions. Enfin, les perspectives apportées par l'ingénierie tissulaire et la bioimpression (création de modèles in vitro complexes) sont détaillées.


Subject(s)
Bioprinting , Oral Surgical Procedures , Humans , Bioprinting/methods , Biocompatible Materials , Tissue Engineering/methods , Printing, Three-Dimensional , Tissue Scaffolds
4.
Article in English | MEDLINE | ID: mdl-38587434

ABSTRACT

Dental implants have been clinically used for almost five decades with high success rates. In vitro research models used in implant dentistry are limited to two-dimensional experiments, which are reproducible and well adapted to evaluate a single parameter but do not reproduce the complexity of clinical settings. On the contrary, the in vivo research models using animals offer similar histological and anatomical features to humans, and tissue healing can be close to a clinical situation, but those models are usually accompanied with ethical concerns, and their outcomes could not be extrapolated to humans because of interspecies variabilities. This makes the development of novel in vitro models that recapitulate physiological events occurring during dental implant placement of particular interest for current research in dentistry. Also, such models could be challenged by setting a pathological environment (peri-implantitis) to better understand the disease and eventually serve as a platform to evaluate novel treatment modalities. The aim of this systematic literature review was to cover all the in vitro three-dimensional (3D) complex models available for research in implant dentistry. To accomplish this, a comprehensive search of the literature present on Scopus and PubMed databases was done using specific keywords, as well as inclusion/exclusion criteria. Out of 1334 articles found, we have finally included 27 articles in this review with publication dates between 2001 and 2022. In those articles, the 3D models were designed to study tissue-implant interface behavior in bone or gingival tissue. The articles focused on simulating implant integration, evaluating the effect of different conditions on implant integration, or developing an infection model for the implant integration process. The methods used involved implant material and cells organized in a specific 3D structure. The 3D models developed were able to simulate the process of dental implant osseo- and soft tissue integration and lead to results comparable with conventional in vitro and in vivo models. A relatively limited number of articles were obtained, which indicates that this is an emerging field, highly dependent on progresses made in biotechnologies and tissue engineering, and that further investigation is needed to enhance these 3D in vitro models.

5.
Bioengineering (Basel) ; 10(11)2023 Oct 28.
Article in English | MEDLINE | ID: mdl-38002381

ABSTRACT

INTRODUCTION: Guided bone regeneration (GBR) procedures require selecting suitable membranes for oral surgery. Pullulan and/or dextran-based polysaccharide materials have shown encouraging results in bone regeneration as bone substitutes but have not been used to produce barrier membranes. The present study aimed to develop and characterize pullulan/dextran-derived membranes for GBR. MATERIALS AND METHODS: Two pullulan/dextran-based membranes, containing or not hydroxyapatite (HA) particles, were developed. In vitro, cytotoxicity evaluation was performed using human bone marrow mesenchymal stem cells (hBMSCs). Biocompatibility was assessed on rats in a subcutaneous model for up to 16 weeks. In vivo, rat femoral defects were created on 36 rats to compare the two pullulan/dextran-based membranes with a commercial collagen membrane (Bio-Gide®). Bone repair was assessed radiologically and histologically. RESULTS: Both polysaccharide membranes demonstrated cytocompatibility and biocompatibility. Micro-computed tomography (micro-CT) analyses at two weeks revealed that the HA-containing membrane promoted a significant increase in bone formation compared to Bio-Gide®. At one month, similar effects were observed among the three membranes in terms of bone regeneration. CONCLUSION: The developed pullulan/dextran-based membranes evidenced biocompatibility without interfering with bone regeneration and maturation. The HA-containing membrane, which facilitated early bone regeneration and offered adequate mechanical support, showed promising potential for GBR procedures.

6.
Eur Cell Mater ; 23: 147-60; discussion 160, 2012 Feb 23.
Article in English | MEDLINE | ID: mdl-22370797

ABSTRACT

Hydrogels that are non-toxic, easy to use, cytocompatible, injectable and degradable are valuable biomaterials for tissue engineering and tissue repair. However, few compounds currently fulfil these requirements. In this study, we describe the biological properties of a new type of thermosensitive hydrogel based on low-molecular weight glycosyl-nucleosyl-fluorinated (GNF) compound. This gel forms within 25 min by self-assembly of monomers as temperature decreases. It degrades slowly in vitro and in vivo. It induces moderate chronic inflammation and is progressively invaded by host cells and vessels, suggesting good integration to the host environment. Although human adult mesenchymal stem cells derived from adipose tissue (ASC) cannot adhere on the gel surface or within a 3D gel scaffold, cell aggregates grow and differentiate normally when entrapped in the GNF-based gel. Moreover, this hydrogel stimulates osteoblast differentiation of ASC in the absence of osteogenic factors. When implanted in mice, gel-entrapped cell aggregates survive for several weeks in contrast with gel-free spheroids. They are maintained in their original site of implantation where they interact with the host tissue and adhere on the extracellular matrix. They can differentiate in situ into alkaline phosphatase positive osteoblasts, which deposit a calcium phosphate-rich matrix. When injected into subcutaneous sites, gel-encapsulated cells show similar biological properties as implanted gel-cells complexes. These data point GNF-based gels as a novel class of hydrogels with original properties, in particular osteogenic potential, susceptible of providing new therapeutic solutions especially for bone tissue engineering applications.


Subject(s)
Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Osteoblasts/metabolism , Surface-Active Agents/chemistry , Tissue Engineering/methods , Tissue Scaffolds , Adipose Tissue/cytology , Animals , Biocompatible Materials/chemistry , Cell Differentiation/physiology , Cell Survival/physiology , Cells, Cultured , Fluorocarbons/chemistry , Humans , Hydrogel, Polyethylene Glycol Dimethacrylate/chemical synthesis , Mice , Molecular Weight , Nucleosides/chemistry , Temperature
7.
J Enzyme Inhib Med Chem ; 26(2): 204-15, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20545489

ABSTRACT

Cell cycle progression is dependent on the intracellular iron level and chelators can lead to iron depletion and decrease cell proliferation. This antiproliferative effect can be inhibited by exogenous iron. In this work, we present the synthesis of some new synthetic calix[4]arene podands bearing diamino-tetraesters, diamino-tetraalcohols, diamino-tetraacid and tetraaryloxypentoxy groups at the lower rim, designed as potential iron chelators. We report their effect on cell proliferation, in comparison with the new oral chelator ICL670A (4-[3,5-bis-(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid). The antiproliferative effect of these new compounds was studied in the human hepatocarcinoma HepaRG cell cultures using cell nuclei counting after staining with the DNA intercalating fluorescence dye, Hoechst 33342. Their cytotoxicity was evaluated by the extracellular LDH activity. Preliminary results indicated that their antiproliferative effect was mainly due to their cytotoxicity. The efficiency of these compounds, being comparable to that of ICL670, was independent of iron depletion. This effect remains to be further explored. Moreover, it also shows that the new substituted calix[4]arenes could open the way to valuable new approaches for medicinal chemistry scaffolding.


Subject(s)
Antineoplastic Agents/pharmacology , Calixarenes/pharmacology , Hepatocytes/drug effects , Phenols/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Calixarenes/chemical synthesis , Calixarenes/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Cells, Cultured , Female , Humans , Liver/cytology , Molecular Structure , Phenols/chemical synthesis , Phenols/chemistry , Solubility
8.
Calcif Tissue Int ; 86(1): 72-81, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19953233

ABSTRACT

In order to identify pertinent models of cortical and cancellous bone regeneration, we compared the kinetics and patterns of bone healing in mouse femur using two defect protocols. The first protocol consisted of a 0.9-mm-diameter through-and-through cortical hole drilled in the mid-diaphysis. The second protocol was a 0.9-mm-diameter, 1-mm-deep perforation in the distal epimetaphyseal region, which destroyed part of the growth plate and cancellous bone. Bone healing was analyzed by ex vivo micro-computerized X-ray tomography and histology. In the diaphysis, the cortical gap was bridged with woven bone within 2 weeks. This newly formed bone was rapidly remodeled into compact cortical bone, which showed characteristic parameters of intact cortex 4 weeks after surgery. In the epimetaphysis, bone formation was initiated at the deepest region of the defect and spread slowly toward the cortical gap. In this position, newly formed bone quickly adopted the characteristics of trabecular bone, whereas a thin compact wall was formed at its external border, which reached the density of intact cortical bone but failed to bridge the cortical gap even 13 weeks after surgery. This comparative study indicates that the diaphyseal defect is a model of cortical bone healing and that the epimetaphyseal defect is a model of cancellous bone repair. These models enable experimental genetics studies to investigate the cellular and molecular mechanisms of spontaneous cortical and cancellous bone repair and may be useful for pharmacological studies.


Subject(s)
Bone Regeneration/physiology , Femur/physiology , Femur/surgery , Wound Healing/physiology , Animals , Diaphyses/injuries , Diaphyses/physiology , Diaphyses/surgery , Disease Models, Animal , Epiphyses/injuries , Epiphyses/physiology , Epiphyses/surgery , Femur/injuries , Male , Mice , Mice, Inbred C57BL , Microsurgery/methods , Orthopedic Procedures/methods , Reproducibility of Results , Species Specificity , X-Ray Microtomography
9.
Thyroid ; 29(9): 1336-1343, 2019 09.
Article in English | MEDLINE | ID: mdl-31303139

ABSTRACT

Background: Inflammation is associated with marked changes in cellular thyroid hormone (TH) metabolism in triiodothyronine (T3) target organs. In the hypothalamus, type 2 deiodinase (D2), the main T3 producing enzyme, increases upon inflammation, leading to an increase in local T3 availability, which in turn decreases thyrotropin releasing hormone expression in the paraventricular nucleus. Type 3 deiodinase (D3), the T3 inactivating enzyme, decreases during inflammation, which might also contribute to the increased T3 availability in the hypothalamus. While it is known that D2 is regulated by nuclear factor κB (NF-κB) during inflammation, the underlying mechanisms of D3 regulation are unknown. Therefore, the aim of the present study was to investigate inflammation-induced D3 regulation using in vivo and in vitro models. Methods: Mice were injected with a sublethal dose of bacterial endotoxin (lipopolysaccharide [LPS]) to induce a systemic acute-phase response. A human neuroblastoma (SK-N-AS) cell line was used to test the involvement of the thyroid hormone receptor alpha 1 (TRα1) as well as the activator protein-1 (AP-1) and NF-κB inflammatory pathways in the inflammation-induced decrease of D3. Results: D3 expression in the hypothalamus was decreased 24 hours after LPS injection in mice. This decrease was similar in mice lacking the TRα. Incubation of SK-N-AS cells with LPS robustly decreased both D3 mRNA expression and activity. This led to increased intracellular T3 concentrations. The D3 decrease was prevented when NF-κB or AP-1 was inhibited. TRα1 mRNA expression decreased in SK-N-AS cells incubated with LPS, but knockdown of the TRα in SK-N-AS cells did not prevent the LPS-induced D3 decrease. Conclusions: We conclude that the inflammation-induced D3 decrease in the hypothalamus is mediated by the inflammatory pathways NF-κB and AP-1, but not TRα1. Furthermore, the observed decrease modulates intracellular T3 concentrations. Our results suggest a concerted action of inflammatory modulators to regulate both hypothalamic D2 and D3 activities to increase the local TH concentrations.


Subject(s)
Hypothalamus/enzymology , Inflammation/metabolism , Iodide Peroxidase/genetics , Animals , Cell Line, Tumor , Down-Regulation , Female , Humans , Iodide Peroxidase/physiology , Lipopolysaccharides , Male , Mice , NF-kappa B/physiology , RNA, Messenger/analysis , Signal Transduction , Thyroid Hormone Receptors alpha/physiology , Transcription Factor AP-1/physiology , Iodothyronine Deiodinase Type II
10.
Mol Endocrinol ; 21(5): 1095-107, 2007 May.
Article in English | MEDLINE | ID: mdl-17327419

ABSTRACT

Thyrotoxicosis is an important but under recognized cause of osteoporosis. Recently, TSH deficiency, rather than thyroid hormone excess, has been suggested as the underlying cause. To investigate the molecular mechanism of osteoporosis in thyroid disease, we characterized the skeleton in mice lacking either thyroid hormone receptor alpha or beta (TRalpha(0/0), TRbeta-/-). Remarkably, in the presence of normal circulating thyroid hormone and TSH concentrations, adult TRalpha(0/0) mice had osteosclerosis accompanied by reduced osteoclastic bone resorption, whereas juveniles had delayed endochondral ossification with reduced bone mineral deposition. By contrast, adult TRbeta-/- mice with elevated TSH and thyroid hormone levels were osteoporotic with evidence of increased bone resorption, whereas juveniles had advanced ossification with increased bone mineral deposition. Analysis of T3 target gene expression revealed skeletal hypothyroidism in TRalpha(0/0) mice, but skeletal thyrotoxicosis in TRbeta-/- mice. These studies demonstrate that bone loss in thyrotoxicosis is independent of circulating TSH levels and mediated predominantly by TRalpha, thus identifying TRalpha as a novel drug target in the prevention and treatment of osteoporosis.


Subject(s)
Hyperthyroidism/physiopathology , Osteoporosis/etiology , Thyroid Hormones/physiology , Thyrotropin/deficiency , Aging , Animals , Animals, Newborn , Bone Density , Bone Resorption/genetics , Bone and Bones/pathology , Bone and Bones/ultrastructure , Embryo, Mammalian , Hyperthyroidism/pathology , Mice , Mice, Knockout , Microscopy, Electron, Scanning , Osteoporosis/genetics , Osteoporosis/pathology , Thyroid Hormone Receptors alpha/deficiency , Thyroid Hormone Receptors alpha/genetics , Thyroid Hormone Receptors beta/deficiency , Thyroid Hormone Receptors beta/genetics , Thyrotropin/physiology
11.
Drug Deliv Transl Res ; 8(1): 178-190, 2018 02.
Article in English | MEDLINE | ID: mdl-29192408

ABSTRACT

Bone morphogenetic protein 2 (BMP-2) is a potent inducer of bone formation that is currently used in a limited number of clinical indications to treat extensive bone loss. Extending the field of applications of this molecule requires design of the delivery system to protect the protein from early degradation and allow a slow long-term release. This study describes the use of a non-polymer hydrogel, based on the self-assembly of small amphiphilic glycosyl-nucleolipids into micellar structures, as a new type of delivery system for BMP-2. BMP-2 was readily encapsulated in glycosyl-nucleosyl-fluorinated (GNF)-based gels and slowly released in vitro, while maintaining its osteogenic activity. When hydrogel pieces containing fluorophore-tagged BMP-2 were deposited onto a calvaria defect in mouse, the signal detected in living mice gradually decreased and was still detectable at 3 weeks. Gel-embedded protein promoted significant calvarial bone defect regeneration at 8 weeks after surgery. In contrast, when a solution of BMP-2 without hydrogel was injected into the defects, the fluorescence signal decreased rapidly and no significant bone formation was observed. The unique property of the GNF-based hydrogel as an injectable delivery system for low doses of BMP-2 was revealed in a subcutaneous model of ectopic bone formation. Injected BMP-2-laden GNF hydrogel blocks elicited the formation of cancellous bone, showing all the typical features of remodeling bone that contains bone marrow. These results show that this GNF-based hydrogel is an easy-to-use, efficient delivery system for BMP-2 and osteogenic material to support bone regeneration.


Subject(s)
Bone Morphogenetic Protein 2/administration & dosage , Bone Regeneration/drug effects , Hydrogels/administration & dosage , Skull/drug effects , Animals , Bone Morphogenetic Protein 2/chemistry , Bone Morphogenetic Protein 2/pharmacokinetics , Cell Differentiation/drug effects , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Drug Liberation , Female , Humans , Hydrogels/chemistry , Hydrogels/pharmacokinetics , Mice , Skull/diagnostic imaging , Skull/injuries , Skull/physiology , Stem Cells/cytology , Stem Cells/drug effects , X-Ray Microtomography
12.
J Tissue Eng Regen Med ; 12(3): e1489-e1500, 2018 03.
Article in English | MEDLINE | ID: mdl-28875562

ABSTRACT

Tissue engineering is a promising alternative to autografts, allografts, or biomaterials to address the treatment of severe and large bone lesions. Classically, tissue engineering products associate a scaffold and cells and are implanted or injected into the lesion. These cells must be embedded in an appropriate biocompatible scaffold, which offers a favourable environment for their survival and differentiation. Here, we designed a composite hydrogel composed of collagen I, an extracellular matrix protein widely used in several therapeutic applications, which we associated with a physical hydrogel generated from a synthetic small amphiphilic molecule. This composite showed improved mechanical and biological characteristics as compared with gels obtained from each separate compound. Incorporation of the physical hydrogel prevented shrinkage of collagen and cell diffusion out of the gel and yielded a gel with a higher elastic modulus than those of gels obtained with each component alone. The composite hydrogel allowed cell adhesion and proliferation in vitro and long-term cell survival in vivo. Moreover, it promoted the differentiation of human adipose-derived stem cells in the absence of any osteogenic factors. In vivo, cells embedded in the composite gel and injected subcutaneously in immunodeficient mice produced lamellar osteoid tissue and differentiated into osteoblasts. This study points this new composite hydrogel as a promising scaffold for bone tissue engineering applications.


Subject(s)
Bone and Bones/physiology , Collagen/pharmacology , Hydrogels/pharmacology , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Adipose Tissue/cytology , Animals , Bone and Bones/drug effects , Carbon/chemistry , Cell Adhesion/drug effects , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Halogenation , Humans , Injections, Subcutaneous , Rats , Stem Cells/cytology , Stem Cells/drug effects
13.
Behav Brain Res ; 177(1): 109-16, 2007 Feb 12.
Article in English | MEDLINE | ID: mdl-17129617

ABSTRACT

Thyroid hormone insufficiency leads to impaired neurogenesis, behavioral alterations and cognitive deficits. Thyroid hormone receptors, expressed in brain regions involved in these behaviors, mediate the effects of thyroid hormone deficiency or excess. To determine the contribution of thyroid hormone receptor alpha (TRalpha) in these behaviors, we examined the behavior of euthyroid as well as hypo- and hyperthyroid mice lacking all isoforms of the TRalpha (TRalpha(o/o)). The hypothyroxinemic TRalpha(o/o) mice demonstrated behavioral inhibition, manifested in decreased activity and increased anxiety/fear in the open field test (OFT) and increased immobility in the forced swim test (FST) compared to C57BL/6J mice. TRalpha(o/o) mice also showed learning and recall impairments in the Morris water maze (MWM), which were exaggerated by hypothyroidism in TRalpha(o/o) mice. These impairments were concurrent with increased thigmotaxis, suggesting an increased anxiety-like state of the TRalpha(o/o) mice in the MWM. Expression of genes, known to be involved in processes modulating learning and memory, such as glucocorticoid receptor (GR), growth-associated protein 43 (GAP-43) and neurogranin (RC3), were significantly decreased in the hippocampus of TRalpha(o/o) mice. GR expression was also decreased in the frontal cortex and amygdala of TRalpha(o/o) mice, indicating that expression of GR is regulated, probably developmentally, by one or more isoforms of TRalpha in the mouse brain. Taken together these data demonstrate behavioral alterations in the TRalpha(o/o) mice, indicating the functional role of TRalpha, and a delicate interaction between TRalpha and TRbeta-regulated genes in these behaviors. Thyroid hormone-regulated genes potentially responsible for the learning deficit found in TRalpha(o/o) mice include GR, RC3 and GAP-43.


Subject(s)
Hypothyroidism/complications , Inhibition, Psychological , Learning Disabilities/etiology , Memory Disorders/etiology , Space Perception/physiology , Thyroid Hormone Receptors alpha/deficiency , Analysis of Variance , Animals , Behavior, Animal/physiology , Exploratory Behavior/physiology , Hypothyroidism/genetics , Male , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/biosynthesis , Radioimmunoassay , Reaction Time/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Swimming
14.
J Tissue Eng ; 8: 2041731417712073, 2017.
Article in English | MEDLINE | ID: mdl-28634532

ABSTRACT

Tissue engineering is a promising alternative to autografts or allografts for the regeneration of large bone defects. Cell-free biomaterials with different degrees of sophistication can be used for several therapeutic indications, to stimulate bone repair by the host tissue. However, when osteoprogenitors are not available in the damaged tissue, exogenous cells with an osteoblast differentiation potential must be provided. These cells should have the capacity to colonize the defect and to participate in the building of new bone tissue. To achieve this goal, cells must survive, remain in the defect site, eventually proliferate, and differentiate into mature osteoblasts. A critical issue for these engrafted cells is to be fed by oxygen and nutrients: the transient absence of a vascular network upon implantation is a major challenge for cells to survive in the site of implantation, and different strategies can be followed to promote cell survival under poor oxygen and nutrient supply and to promote rapid vascularization of the defect area. These strategies involve the use of scaffolds designed to create the appropriate micro-environment for cells to survive, proliferate, and differentiate in vitro and in vivo. Hydrogels are an eclectic class of materials that can be easily cellularized and provide effective, minimally invasive approaches to fill bone defects and favor bone tissue regeneration. Furthermore, by playing on their composition and processing, it is possible to obtain biocompatible systems with adequate chemical, biological, and mechanical properties. However, only a good combination of scaffold and cells, possibly with the aid of incorporated growth factors, can lead to successful results in bone regeneration. This review presents the strategies used to design cellularized hydrogel-based systems for bone regeneration, identifying the key parameters of the many different micro-environments created within hydrogels.

15.
Biomaterials ; 145: 72-80, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28850933

ABSTRACT

There is a critical need for soft materials in the field of regenerative medicine and tissue engineering. However, designing injectable hydrogel scaffolds encompassing both adequate mechanical and biological properties remains a key challenge for in vivo applications. Here we use a bottom-up approach for synthesizing supramolecular gels to generate novel biomaterial candidates. We evaluated the low molecular weight gels candidates in vivo and identified one urea-containing molecule, compound 16, that avoid foreign body reactions in mice. The self-assembly of bolaamphiphiles creates a unique hydrogel supramolecular structures featuring fast gelation kinetics, high elastic moduli, thixotropic, and thermal reversibility properties. This soft material, which inhibits recognition by macrophages and fibrous deposition, exhibits long-term stability after in vivo injection.


Subject(s)
Biocompatible Materials/pharmacology , Furans/pharmacology , Hydrogels/pharmacology , Injections , Pyridones/pharmacology , Urea/chemistry , Amides/chemistry , Animals , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Female , Furans/chemistry , Hydrogels/chemical synthesis , Hydrogels/chemistry , Mice , Molecular Weight , Pyridones/chemistry , Rheology
16.
Adv Mater ; 29(13)2017 Apr.
Article in English | MEDLINE | ID: mdl-28151562

ABSTRACT

Hydrogels formed by the self-assembly of low-molecular-weight gelators (LMWGs) are promising scaffolds for drug-delivery applications. A new biocompatible hydrogel, resulting from the self-assembly of nucleotide-lipid salts can be safely injected in vivo. The resulting hydrogel provides sustained-release of protein for more than a week.


Subject(s)
Biocompatible Materials/chemistry , Cations/chemistry , Drug Delivery Systems , Hydrogels/chemistry , Animals , Cattle , Fluorescent Dyes/administration & dosage , Fluorescent Dyes/pharmacokinetics , Hydrophobic and Hydrophilic Interactions , Lipids/chemistry , Materials Testing , Mice , Microscopy, Electron, Transmission , Rheology , Salts/chemistry , Serum Albumin, Bovine/administration & dosage , Serum Albumin, Bovine/pharmacokinetics , Static Electricity , Subcutaneous Absorption
17.
Biomed Res Int ; 2016: 3569843, 2016.
Article in English | MEDLINE | ID: mdl-27833916

ABSTRACT

Tissue engineering of large organs is currently limited by the lack of potent vascularization in vitro. Tissue-engineered bone grafts can be prevascularized in vitro using endothelial cells (ECs). The microvascular network architecture could be controlled by printing ECs following a specific pattern. Using laser-assisted bioprinting, we investigated the effect of distance between printed cell islets and the influence of coprinted mesenchymal cells on migration. When printed alone, ECs spread out evenly on the collagen hydrogel, regardless of the distance between cell islets. However, when printed in coculture with mesenchymal cells by laser-assisted bioprinting, they remained in the printed area. Therefore, the presence of mesenchymal cell is mandatory in order to create a pattern that will be conserved over time. This work describes an interesting approach to study cell migration that could be reproduced to study the effect of trophic factors.


Subject(s)
Bioprinting/methods , Cell Movement , Human Umbilical Vein Endothelial Cells/metabolism , Lasers , Mesenchymal Stem Cells/metabolism , Coculture Techniques , Female , Human Umbilical Vein Endothelial Cells/cytology , Humans , Male , Mesenchymal Stem Cells/cytology
18.
Endocrinology ; 146(12): 5568-80, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16150908

ABSTRACT

Childhood hypothyroidism causes growth arrest with delayed ossification and growth-plate dysgenesis, whereas thyrotoxicosis accelerates ossification and growth. Thyroid hormone (T(3)) regulates chondrocyte proliferation and is essential for hypertrophic differentiation. Fibroblast growth factors (FGFs) are also important regulators of chondrocyte proliferation and differentiation, and activating mutations of FGF receptor-3 (FGFR3) cause achondroplasia. We investigated the hypothesis that T(3) regulates chondrogenesis via FGFR3 in ATDC5 cells, which undergo a defined program of chondrogenesis. ATDC5 cells expressed two FGFR1, four FGFR2, and one FGFR3 mRNA splice variants throughout chondrogenesis, and expression of each isoform was stimulated by T(3) during the first 6-12 d of culture, when T(3) inhibited proliferation by 50%. FGFR3 expression was also increased in cells treated with T(3) for 21 d, when T(3) induced an earlier onset of hypertrophic differentiation and collagen X expression. FGFR3 expression was reduced in growth plates from T(3) receptor alpha-null mice, which exhibit skeletal hypothyroidism, but was increased in T(3) receptor beta(PV/PV) mice, which display skeletal thyrotoxicosis. These findings indicate that FGFR3 is a T(3)-target gene in chondrocytes. In further experiments, T(3) enhanced FGF2 and FGF18 activation of the MAPK-signaling pathway but inhibited their activation of signal transducer and activator of transcription-1. FGF9 did not activate MAPK or signal transducer and activator of transcription-1 pathways in the absence or presence of T(3). Thus, T(3) exerted differing effects on FGFR activation during chondrogenesis depending on which FGF ligand stimulated the FGFR and which downstream signaling pathway was activated. These studies identify novel interactions between T(3) and FGFs that regulate chondrocyte proliferation and differentiation during chondrogenesis.


Subject(s)
Chondrogenesis/physiology , Receptors, Fibroblast Growth Factor/metabolism , Signal Transduction/physiology , Triiodothyronine/physiology , Animals , Base Sequence , Cell Differentiation/physiology , Cells, Cultured , Chondrogenesis/drug effects , Enzyme Activation/physiology , Mice , Mice, Knockout , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/metabolism , Receptors, Fibroblast Growth Factor/genetics , Receptors, Fibroblast Growth Factor/physiology , Receptors, Thyroid Hormone/deficiency , Triiodothyronine/pharmacology
19.
Mol Endocrinol ; 17(5): 882-94, 2003 May.
Article in English | MEDLINE | ID: mdl-12576486

ABSTRACT

Steroid receptor coactivator-1 (SRC-1) is a transcription cofactor that enhances the hormone-dependent action mediated by the thyroid hormone (TH) receptor (TR) as well as other nuclear receptors. However, it is not known whether the SRC-1-mediated activation of TH-regulated gene transcription is TR isoform specific in the pituitary. We generated mice that were deficient in TRalpha and SRC-1 (TRalpha(0/0)SRC-1(-/-)), as well in TRbeta and SRC-1 (TRbeta(-/-)SRC-1(-/-)), and thyroid function tests and effects of TH deprivation and TH treatment were compared with wild-type mice or mice with deletion of either TRs or SRC-1 alone. We have shown that 1) TRbeta(-/-)SRC-1(-/-) mice demonstrate more severe TH resistance than either the SRC-1(-/-) or TRbeta(-/-) mice; the additive effect indicates that SRC-1 has an independent role in TH action over that of TRbeta; 2) SRC-1 facilitates TRbeta and TRalpha-mediated down-regulation of TSH, as TRalpha(0/0)SRC-1(-/-) mice demonstrate TH resistance rather than hypersensitivity as seen in TRalpha(0/0)mice; and 3) a compensatory increase in SRC-1 expression is associated with the TH hypersensitivity seen in TRalpha-deficient animals. We conclude that SRC-1 action in the pituitary mediates TH action via specific TR subtypes.


Subject(s)
Pituitary Gland/physiology , Receptors, Thyroid Hormone/metabolism , Thyroid Hormone Receptors alpha/metabolism , Transcription Factors/metabolism , Animals , Cell Nucleus/metabolism , Female , Histone Acetyltransferases , Male , Mice , Mice, Mutant Strains , Nuclear Receptor Coactivator 1 , Nuclear Receptor Coactivator 2 , Nuclear Receptor Coactivator 3 , Pituitary Gland/drug effects , RNA, Messenger/drug effects , Receptors, Thyroid Hormone/genetics , Thyroid Function Tests , Thyroid Hormone Receptors alpha/genetics , Thyroid Hormone Receptors beta , Thyroid Hormone Resistance Syndrome/drug therapy , Thyroid Hormone Resistance Syndrome/genetics , Thyroid Hormone Resistance Syndrome/metabolism , Thyroid Hormones/deficiency , Thyroid Hormones/metabolism , Thyroid Hormones/pharmacology , Thyrotropin/blood , Thyrotropin/genetics , Thyrotropin/metabolism , Thyrotropin, beta Subunit/drug effects , Thyrotropin, beta Subunit/genetics , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Triiodothyronine/metabolism
20.
Mol Endocrinol ; 16(1): 24-32, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11773436

ABSTRACT

Mice devoid of all TRs are viable, whereas Pax8(-/-) mice, which lack the follicular cells producing T4 and T3 in the thyroid gland, die during the first weeks of postnatal life. A precise comparison between the two types of mutants reveals that their phenotypes are similar, but the defects in spleen, bone, and small intestine are more pronounced in Pax8(-/-) mice. This is interpreted as the result of a negative effect of the unliganded TR on thyroid hormone target genes expression in the Pax8(-/-) mutants. Pax8/TRalpha compound mutants can survive to adulthood, and the expression of target genes is partially restored. This demonstrates the importance of TRalpha aporeceptor activity in several aspects of postnatal development.


Subject(s)
DNA-Binding Proteins/genetics , Hypothyroidism/genetics , Hypothyroidism/physiopathology , Nuclear Proteins , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Thyroid Hormone , Trans-Activators/genetics , Animals , Congenital Hypothyroidism , DNA-Binding Proteins/metabolism , Gene Expression Regulation , Gene Silencing , Homozygote , Mice , Mice, Mutant Strains , PAX8 Transcription Factor , Paired Box Transcription Factors , Receptors, Cytoplasmic and Nuclear/metabolism , Spleen/pathology , Survival Rate , Thyroid Gland/physiopathology , Thyrotropin/metabolism , Trans-Activators/metabolism , Triiodothyronine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL